These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 21559817)

  • 1. Update on hormonal contraception and bone density.
    Isley MM; Kaunitz AM
    Rev Endocr Metab Disord; 2011 Jun; 12(2):93-106. PubMed ID: 21559817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal contraception and bone metabolism: a systematic review.
    Nappi C; Bifulco G; Tommaselli GA; Gargano V; Di Carlo C
    Contraception; 2012 Dec; 86(6):606-21. PubMed ID: 22717184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.
    Kaunitz AM
    Int J Fertil Womens Med; 1998; 43(2):73-83. PubMed ID: 9609206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroidal contraceptives and bone fractures in women: evidence from observational studies.
    Lopez LM; Chen M; Mullins S; Curtis KM; Helmerhorst FM
    Cochrane Database Syst Rev; 2012 Aug; (8):CD009849. PubMed ID: 22895991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroidal contraceptives: effect on bone fractures in women.
    Lopez LM; Grimes DA; Schulz KF; Curtis KM
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006033. PubMed ID: 19370623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study.
    Cromer BA; Bonny AE; Stager M; Lazebnik R; Rome E; Ziegler J; Camlin-Shingler K; Secic M
    Fertil Steril; 2008 Dec; 90(6):2060-7. PubMed ID: 18222431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception.
    Wanichsetakul P; Kamudhamas A; Watanaruangkovit P; Siripakarn Y; Visutakul P
    Contraception; 2002 Jun; 65(6):407-10. PubMed ID: 12127638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone density in women receiving depot medroxyprogesterone acetate for contraception.
    Cundy T; Evans M; Roberts H; Wattie D; Ames R; Reid IR
    BMJ; 1991 Jul; 303(6793):13-6. PubMed ID: 1830502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone density recovery after depot medroxyprogesterone acetate injectable contraception use.
    Kaunitz AM; Arias R; McClung M
    Contraception; 2008 Feb; 77(2):67-76. PubMed ID: 18226668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture.
    Lanza LL; McQuay LJ; Rothman KJ; Bone HG; Kaunitz AM; Harel Z; Ataher Q; Ross D; Arena PL; Wolter KD
    Obstet Gynecol; 2013 Mar; 121(3):593-600. PubMed ID: 23635623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
    Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
    J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects on bone density of progestogen-only methods for contraception in premenopausal women.
    Naessen T; Olsson SE; Gudmundson J
    Contraception; 1995 Jul; 52(1):35-9. PubMed ID: 8521712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK.
    Kyvernitakis I; Kostev K; Nassour T; Thomasius F; Hadji P
    Osteoporos Int; 2017 Jan; 28(1):291-297. PubMed ID: 27461017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroidal contraceptives: effect on bone fractures in women.
    Lopez LM; Grimes DA; Schulz KF; Curtis KM
    Cochrane Database Syst Rev; 2011 Jul; (7):CD006033. PubMed ID: 21735401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10.
    Lidegaard O; Nielsen LH; Skovlund CW; Løkkegaard E
    BMJ; 2012 May; 344():e2990. PubMed ID: 22577198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroidal contraceptives: effect on bone fractures in women.
    Lopez LM; Grimes DA; Schulz KF; Curtis KM
    Cochrane Database Syst Rev; 2006 Oct; (4):CD006033. PubMed ID: 17054270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hormonal contraception on bone mineral density after 24 months of use.
    Berenson AB; Breitkopf CR; Grady JJ; Rickert VI; Thomas A
    Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestogen-only contraception and bone mineral density: a systematic review.
    Curtis KM; Martins SL
    Contraception; 2006 May; 73(5):470-87. PubMed ID: 16627031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone loss associated with long-term use of depot medroxyprogesterone acetate.
    Lo SS; Fan SY;
    Hong Kong Med J; 2005 Dec; 11(6):491-5. PubMed ID: 16340026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
    Piya-Anant M; Koetsawang S; Patrasupapong N; Dinchuen P; d'Arcangues C; Piaggio G; Pinol A
    Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.